Guru Fundamental Report for JNJ

Validea's guru fundamental report rates Johnson & Johnson (JNJ) at 77% using Partha Mohanram's P/B Growth Investor model, which identifies low book-to-market stocks exhibiting sustained future growth potential. JNJ, a large-cap biotechnology and drugs stock, passes most key financial health metrics, including return on assets and cash flow, but notably fails on advertising and research & development to assets. This places JNJ just below the 80% threshold for strategic interest within this outperforming growth strategy, indicating strong fundamental performance with specific areas of concern for growth-oriented investors.

Analysis

Johnson & Johnson (JNJ) scores a 77% rating under Validea's P/B Growth Investor model, a quantitative strategy derived from academic Partha Mohanram's research on identifying high-growth stocks. This score indicates a solid fundamental profile but places the company just below the 80% threshold that typically signifies strategic interest from the model. JNJ, a large-cap in the Biotechnology & Drugs sector, demonstrates significant financial health by passing key tests for its book-to-market ratio, return on assets (ROA), and cash flow from operations relative to assets. Furthermore, the company exhibits stability, passing criteria for variance in both ROA and sales. However, the analysis reveals critical weaknesses from a growth perspective, as JNJ fails the model's criteria for both Advertising to Assets and Research and Development to Assets. This suggests that while the company's current operational and financial standing is robust, its investment in key future growth drivers like marketing and innovation may be considered insufficient by this specific growth-oriented framework.

Key Decisions for Investors

• Investors should weigh JNJ's strong current financial health, evidenced by its high return on assets and stable cash flows, against potential concerns about its long-term growth trajectory due to lower-than-ideal spending on R&D and advertising.
• Growth-oriented investors may consider placing JNJ on a watch list, monitoring for any strategic shifts toward increased investment in research and development or marketing, which could push its model score above the 80% interest threshold.
• Given the moderately positive sentiment and the blend of strong fundamentals with flagged growth metrics, current holders might maintain their position while evaluating whether the company's stability justifies the potential lack of aggressive growth investment.